Irbesartan vs Methotrexate
Irbesartan vs Methotrexate: Overview
This comparison examines the pharmacological differences between Irbesartan and Methotrexate.
Mechanism of Action
Irbesartan: Selective non-competitive angiotensin II type 1 receptor antagonist.
Methotrexate: Dihydrofolate reductase inhibitor.
Pharmacokinetics
Half-life: Irbesartan β 11-15 hours; Methotrexate β 3-10 hours.
Chemical Properties
Molecular Formula: Irbesartan β C25H28N6O; Methotrexate β C20H22N8O5.
Molecular Weight: Irbesartan β 428.5320 g/mol; Methotrexate β 454.4400 g/mol.
Type: Irbesartan β Small molecule; Methotrexate β Small molecule.